+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A randomized clinical trial of therapeutic hypothermia mode during transport for neonatal encephalopathy

A randomized clinical trial of therapeutic hypothermia mode during transport for neonatal encephalopathy

Journal of Pediatrics 166(4): 856

To determine if temperature regulation is improved during neonatal transport using a servo-regulated cooling device when compared with standard practice. We performed a multicenter, randomized, nonmasked clinical trial in newborns with neonatal encephalopathy cooled during transport to 9 neonatal intensive care units in California. Newborns who met institutional criteria for therapeutic hypothermia were randomly assigned to receive cooling according to usual center practices vs device servo-regulated cooling. The primary outcome was the percentage of temperatures in target range (33°-34°C) during transport. Secondary outcomes included percentage of newborns reaching target temperature any time during transport, time to target temperature, and percentage of newborns in target range 1 hour after cooling initiation. One hundred newborns were enrolled: 49 to control arm and 51 to device arm. Baseline demographics did not differ with the exception of cord pH. For each subject, the percentage of temperatures in the target range was calculated. Infants cooled using the device had a higher percentage of temperatures in target range compared with control infants (median 73% [IQR 17-88] vs 0% [IQR 0-52], P < .001). More subjects reached target temperature during transport using the servo-regulated device (80% vs 49%, P <.001), and in a shorter time period (44 ± 31 minutes vs 63 ± 37 minutes, P = .04). Device-cooled infants reached target temperature by 1 hour with greater frequency than control infants (71% vs 20%, P < .001). Cooling using a servo-regulated device provides more predictable temperature management during neonatal transport than does usual care for outborn newborns with neonatal encephalopathy.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 057090317

Download citation: RISBibTeXText

PMID: 25684087

DOI: 10.1016/j.jpeds.2014.12.061

Related references

Altered circulating leukocytes and their chemokines in a clinical trial of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy*. Pediatric Critical Care Medicine 14(8): 786-795, 2013

Pilot randomized trial of therapeutic hypothermia with serial cranial ultrasound and 18-22 month follow-up for neonatal encephalopathy in a low resource hospital setting in Uganda: study protocol. Trials 12: 138, 2011

Effect of Therapeutic Hypothermia Initiated After 6 Hours of Age on Death or Disability Among Newborns With Hypoxic-Ischemic Encephalopathy: A Randomized Clinical Trial. JAMA 318(16): 1550-1560, 2017

A Quality Initiative for Optimal Therapeutic Hypothermia during Transport for Neonates with Neonatal Encephalopathy. Pediatric Quality and Safety 3(2): E056, 2018

Therapeutic hypothermia changes the prognostic value of clinical evaluation of neonatal encephalopathy. Journal of Pediatrics 152(1): 55-8 58.E1, 2008

Lessons learned during implementation of therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy in a regional transport program in Ontario. Paediatrics and Child Health 16(3): 153-156, 2011

Outcomes of safety and effectiveness in a multicenter randomized, controlled trial of whole-body hypothermia for neonatal hypoxic-ischemic encephalopathy. Pediatrics 122(4): E791-E798, 2008

Clinical seizures in neonatal hypoxic-ischemic encephalopathy have no independent impact on neurodevelopmental outcome: secondary analyses of data from the neonatal research network hypothermia trial. Journal of Child Neurology 26(3): 322-328, 2011

Therapeutic hypothermia for acute liver failure: toward a randomized, controlled trial in patients with advanced hepatic encephalopathy. Neurocritical Care 9(1): 90-96, 2008

Serum cytokines in a clinical trial of hypothermia for neonatal hypoxic-ischemic encephalopathy. Journal of Cerebral Blood Flow & Metabolism 32(10): 1888-1896, 2012

Selective head cooling with mild systemic hypothermia after neonatal hypoxic-ischemic encephalopathy: a multicenter randomized controlled trial in China. Journal of Pediatrics 157(3): 367-72 372.E1-3, 2010

Therapeutic hypothermia using gel packs for term neonates with hypoxic ischaemic encephalopathy in resource-limited settings: a randomized controlled trial. Journal of Tropical Pediatrics 58(5): 382-388, 2012

PS-154Has Therapeutic Hypothermia (th) Changed The Prognostic Value Of Clinical Evaluation Of Neonatal Hypoxic-ischaemic Encephalopathy (hie)? A Systematic Review And Meta-analysis. Archives of Disease in Childhood 99(Suppl 2): A166.3-A167, 2014

Therapeutic hypothermia for neonatal encephalopathy implications for neonatal units in India. Indian Pediatrics 46(4): 283-289, 2009

Therapeutic Hypothermia for Neonatal Encephalopathy in Indian Neonatal Units: A Survey of National Practices. Indian Pediatrics 54(11): 969-970, 2017